gastrointestinal disease
| 2 min read
Expanded high-value end-to-end solution positions business for rapid growth in multi-billion dollar functional GI market
| 3 min read
Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.
| 3 min read
Researchers developed a new pill with promising applications for treating pain due to gastrointestinal disorders.
Available on Demand
Spatial biology platforms shed light on the cellular and molecular players underlying ulcerative colitis and Crohn’s disease.
| 3 min read
Scientists created a pill that, when swallowed, collects snapshots of the gastrointestinal microbiome, revealing striking differences along the GI tract.
| 5 min read
By engineering a probiotic with tiny antibodies from alpacas, scientists created a potential new oral tool to treat deadly diarrheal infections.
| 2 min read
New Mount Sinai study identifies a novel approach for tailored treatment that could be more effective for patients
| 4 min read
Progenity presents results on PIL Dx capsule in small intestinal bacterial overgrowth
| 3 min read
Researchers have discovered that mast cell reactions are behind irritable bowel syndrome
| 2 min read
Tiziana and Parexel will conduct Phase 1b/2 study of take-home capsules of Foralumab, an anti-CD3 monoclonal antibody
